about
Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cellsInsulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathwaysSelective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferationMinireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.Dopamine receptors in human adipocytes: expression and functionsProlactin expression and secretion by human breast glandular and adipose tissue explants.Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.What can we learn from rodents about prolactin in humans?Prolactin as an autocrine/paracrine growth factor in human cancer.Lactogens and estrogens in breast cancer chemoresistance.Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissueKnockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic AgentsFocus on prolactin as a metabolic hormone.The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinomaBisphenols Come in Different Flavors: Is "S" Better Than "A"?Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes.Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat dietEstrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue.Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome.Placental lactogen is expressed but is not translated into protein in breast cancer.Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.Prolactin in breast and prostate cancer: molecular and genetic perspectives.Prolactin (PRL) in adipose tissue: regulation and functions.LS14: a novel human adipocyte cell line that produces prolactin.Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.Adipogenic effect of calcium sensing receptor activation.Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line.LS14 cells: a model for chemoresistance in liposarcoma.Differential expression of VEGF-A mRNA by 17beta-estradiol in breast tumor cells lacking classical ER-alpha may be mediated through a variant form of ER-alpha.Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice.Dopamine and transforming growth factor-beta1: an odd couple in growth inhibition of the lactotrophs.Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.The prolactin-deficient mouse has an unaltered metabolic phenotype.
P50
Q24596235-5A0B9BAE-AADC-4D52-9A74-92362719A36CQ24656266-E309F50B-91B7-40B5-9971-7E82E05B63BAQ33564204-D016AA26-CC3B-42F0-9E0A-A306561F156DQ33632082-8D27F602-0634-41A7-BDC4-6162F578C1A4Q34038390-A8E8913F-51C7-426B-9F58-5987FE7F06D1Q34175869-E6280F54-7169-4CAB-90DF-73FD4577381BQ34258777-C4DF2997-80C1-473C-B483-3797ABCDD2F0Q34425730-FE79B6BA-2A44-4923-B8B7-F2DC3DD71841Q34721567-15C598D0-A04A-49AC-A309-41450165A708Q34750801-437DEA89-19D2-461F-BF82-1A58EDD915B3Q35075176-902AC4C7-655E-45D7-867E-3183736B6DE6Q35830213-D73E6902-F4B1-4B0B-A408-A9A6E1FC3E77Q35857227-766D06EE-9A39-4F0C-8A39-9EBE13205625Q36413921-86641AF1-488B-4585-973C-B5B8CCE2A362Q36458158-DDFCE22D-B19E-493D-9C12-1263A9FA7453Q36753872-47DC6079-B639-49B8-A4FB-6ED88A7C2AA0Q36964871-0F271BE7-EC91-4551-B05D-ECE59F533771Q37007971-1AA65DF9-CE8D-40FD-BE06-C43A4637F9E0Q37047453-68CE6088-013B-4782-9074-FCBFF3122414Q37106608-82D79E0A-E48F-4FD9-87C9-E65AEE05E0C2Q37112491-527D1E53-6943-4627-8138-2730EF05E91FQ37144633-69B782F3-84F6-421A-B9C1-7BD8BAFD69DBQ37281667-58DB1C4A-6960-4BAD-9259-A9E8BDCE44ECQ37298081-15FCFF50-071F-4B3F-9173-6B85A06939EDQ37416840-B9428B31-C762-4594-B38A-5BA9B1D5229DQ37514600-0C26D83D-DDD4-4BC9-B4C7-A326B04086ADQ37673535-F565A458-103B-4FA8-9933-9922E11285C4Q37869569-0D274F37-2A7D-43D1-9AED-0D08DBF89C23Q38282713-3E7C9F24-71E0-4BA5-A009-F64CC9D3D354Q38320463-C2320E8D-6FDB-4C0B-8A7E-8D71C3830959Q38724210-D771B2C7-C004-4863-B421-E7B2FA245F2FQ39100212-825F91D3-1C41-4D13-816B-0F861521D770Q39686033-8FED2216-5DB2-42FF-9E10-A993B1AB5EEAQ40147116-78DAC88B-02BE-4F89-A22E-0810F9A5D970Q40494490-F9F71327-823E-419E-87BE-E23C4C0E1496Q40659599-96E37FD6-8BFF-40EC-9940-C192956B8AB2Q45998546-9786C5EE-3A3B-4A9B-9C66-D4407AC344AAQ46706059-E64F84BD-4F2B-435C-9DCE-24C08FAA6E9FQ47805457-A5250EA2-F1E1-4112-81B8-EF45431E2155Q51797720-6B79860D-A6B9-4933-B4D6-C3F0C1BEC026
P50
name
Nira Ben-Jonathan
@en
Nira Ben-Jonathan
@nl
type
label
Nira Ben-Jonathan
@en
Nira Ben-Jonathan
@nl
prefLabel
Nira Ben-Jonathan
@en
Nira Ben-Jonathan
@nl